| 第18/2023號法律 修改第17/2009號法律《禁止不法生產、販賣和吸食麻醉藥品及精神藥物》 2023年11月20日 |
| 《第18/2023號法律》經立法會於2023年11月7日通過本法律，行政長官賀一誠於2023年11月9日發佈本法律，並於2023年11月20日刊登於《澳門特別行政區公報》。 |
立法會根據《澳門特別行政區基本法》第七十一條（一）項，制定本法律。
第一條 修改第17/2009號法律的附表
一、在經第4/2014號法律、第10/2016號法律、第10/2019號法律、第22/2020號法律及第10/2021號法律修改的第17/2009號法律第四條第二款所指的表一A、表二A、表二B及表二C中分別增加以下物質，該等物質載於作為本法律組成部分的附件一：
（一）表一A：
（1）奧列巴文；
（2）鄰氟芬太尼；
（3）異硝氮烯；
（4）溴啡；
（5）甲硝苯；
（二）表二A：
（1）3-甲氧基苯環利定；
（2）二苯基乙基哌啶；
（三）表二B：
（1）CUMYL-PEGACLON；
（2）MDMB-4en-PINACA；
（四）表二C：氟胺酮。
二、在第17/2009號法律第四條第四款所指的表四中，增加三種物質：氯氮唑侖、二氯西泮及氟溴唑侖；該等物質載於作為本法律組成部分的附件一。
三、在第17/2009號法律第四條第五款所指的表五中，增加三種物質：4-AP、1-boc-4-AP及去甲芬太尼；該等物質載於作為本法律組成部分的附件一。
第二條 修改表述
第17/2009號法律的中文文本所表述的“阿片疊”改為“阿片劑”。
第三條 取代
一、第17/2009號法律第十一條第二款所指的每日用量參考表，由作為本法律組成部分的附件二所載每日用量參考表取代。
二、第17/2009號法律第四條所指的表一至表六，分別由作為本法律組成部分的附件三所載表一至表六取代。
第四條 生效
本法律自公佈翌日起生效。
二零二三年十一月七日通過。
立法會主席 高開賢
二零二三年十一月九日簽署。
命令公佈。
行政長官 賀一誠
附件一
［第一條第一款（一）項所指者］ 表一A
| 編號 | 中文名稱 | 葡文名稱 | 化學名稱∕結構 |
|---|---|---|---|
| 133 | 奧列巴文 | Oripavina | 3-O-demethylthebaine |
| 134 | 鄰氟芬太尼 | Orthofluorofentanyl | N-(2-fluorophenyl)-N-[1-(2-phenylethyl)piperidin-4-yl]propanamide |
| 135 | 異硝氮烯 | Isotonitazene | N,N-diethyl-2-[2-(4-isopropoxybenzyl)-5-nitro--1H-benzo[d]imidazol-1-yl]ethan-1-amine |
| 136 | 溴啡 | Brorphine | 11-[1-(4-bromophenyl)ethyl]-piperidin-4-yl1,3-dihydro-2H-benzimidazol-2-one |
| 137 | 甲硝苯 | Metonitazene | N,N-diethyl-2-[2-(4-methoxybenzyl)-5-nitro-1H--benzo[d]imidazol-1-yl]ethan-1-amine |
［第一條第一款（二）項所指者］ 表二A
| 編號 | 中文名稱 | 葡文名稱 | 化學名稱∕結構 |
|---|---|---|---|
| 43 | 3-甲氧基苯環利定 | 3-Methoxyphencyclidine | 1-[1-(3-methoxyphenyl)cyclohexyl]piperidine |
| 44 | 二苯基乙基哌啶 | Diphenidine | 1-(1,2-diphenylethyl)piperidine |
［第一條第一款（三）項所指者］ 表二B
| 編號 | 中文名稱 | 葡文名稱 | 化學名稱∕結構 |
|---|---|---|---|
| 39 | CUMYL-PEGACLON | CUMYL-PEGACLON | 5-pentyl-2-(2-phenylpropan-2-yl)-2,5-dihydro-1H-pyrido[4,3-b]indol-1-one |
| 40 | MDMB-4en-PINACA | MDMB-4en-PINACA | methyl 3,3-dimethyl-2-[1-(pent-4-en-1-yl)-1H-indazole-3-carboxamido]butanoate |
［第一條第一款（四）項所指者］ 表二C
| 編號 | 中文名稱 | 葡文名稱 | 化學名稱∕結構 |
|---|---|---|---|
| 14 | 氟胺酮 | 2-Fluorodeschloroketamine, 2-FDCK | 2-(2-fluorophenyl)-2-(methylamino)cyclohexan-1-one |
（第一條第二款所指者） 表四
| 編號 | 中文名稱 | 葡文名稱 | 化學名稱∕結構 |
|---|---|---|---|
| 65 | 氯氮唑侖 | Clonazolam | 6-(2-chlorophenyl)-1-methyl-8-nitro-4H- -benzo[f][1,2,4]triazolo[4,3-a][1,4]diazepine |
| 66 | 二氯西泮 | Diclazepam | 7-chloro-5-(2-chlorophenyl)-1-methyl-1,3--dihydro-2H-benzo[e][1,4]diazepin-2-one |
| 67 | 氟溴唑侖 | Flubromazolam | 8-bromo-6-(2-fluorophenyl)-1-methyl-4H--benzo[f][1,2,4]triazolo[4,3-a][1,4]diazepine |
（第一條第三款所指者） 表五
| 編號 | 中文名稱 | 葡文名稱 | 化學名稱∕結構 |
|---|---|---|---|
| 23 | 4-AP | 4-AP | 4-piperidinamine, N-phenyl- |
| 24 | 1-boc-4-AP | 1-boc-4-AP | 4-(phenylamino)-1-piperidinecarboxylic acid, 1,1-dimethylethyl ester |
| 25 | 去甲芬太尼 | Norfentanyl | propanamide, N-phenyl-N-4-piperidinyl- |
附件二 （第三條第一款所指者） 每日用量參考表
| 序號 | 最經常吸食的表一至表四所列植物、物質或製劑 | 表 | 每日參考用量【附註】 |
|---|---|---|---|
| 1. | 海洛因 | I-A | 0.25克【註1及註2】 |
| 2. | 美沙酮 | I-A | 0.1克【註2】 |
| 3. | 嗎啡 | I-A | 0.2克 |
| 4. | 阿片（罌粟汁凝固物） | I-A | 1克【註3-（2）】 |
| 5. | 鹽酸可卡因 | I-B | 0.2克【註2及註4】 |
| 6. | 可卡因（苯甲酰芽子鹼甲酯） | I-B | 0.03克【註2及註4】 |
| 7. | 大麻（植物的葉，或其開花或結果的頂部） | I-C | 1克【註1】 |
| 8. | 大麻樹脂 | I-C | 0.5克【註3-（3）及（4）】 |
| 9. | 大麻油 | I-C | 0.25克【註3-（5）】 |
| 10. | 苯環利定 | II-A | 0.01克【註3-（1）】 |
| 11. | 麥角二乙胺 | II-A | 0.0002克【註1】 |
| 12. | 亞甲二氧基甲基苯丙胺 | II-A | 0.15克【註3-（1）及（6）】 |
| 13. | 苯丙胺 | II-B | 0.2克【註1】 |
| 14. | 甲基苯丙胺 | II-B | 0.2克【註1】 |
| 15. | Δ-9-四氫大麻酚 | II-B | 0.05克 |
| 16. | 氯胺酮 | II-C | 0.6克【註3-（1）】 |
註：
1. 所指的參考量是按照國際麻醉品管制局（INCB — International Narcotics Control Board）的資料而制定。
2. 所指的參考量是按照有關慣常使用量的流行病學的資料而制定。
3. 所指的參考量為：
（1）官方藥物文件內所指的每日用量；
（2）效力相等於可參考的濫用物質的用量；
（3）按大麻產品所含的四氫大麻酚的平均含量的變數所定的每日平均用量；
（4）平均濃度為百分之十的Δ-9-四氫大麻酚；
（5）平均濃度為百分之二十的Δ-9-四氫大麻酚；
（6）在醫學文獻內所指的含有介乎80毫克至160毫克純正物質的慣常平均用量（ca. 2 mg/kg）。然而，某些物質亦有可能混有雜質（如替苯丙胺、咖啡因）或摻合了海洛因。
4. 由於鹽酸可卡因及苯甲酰芽子鹼甲酯的化學成分的效價存在明顯不同，因此特別對兩者訂定了不同的用量。
附件三 （第三條第二款所指者）
表一 A
| 編號 | 中文名稱 | 葡文名稱 | 化學名稱∕結構 |
|---|---|---|---|
| 1 | 乙酰阿法甲基芬太尼 | Acetil-alfa-metilfentanil | N-[1-(α-methylphenethyl)-4-piperidyl]acetanilide |
| 2 | 醋氫可待因 | Acetildiidrocodeína | 3-methoxy-4,5-epoxy-6-acetoxy-17-methylmorphinan |
| 3 | 醋美沙朵 | Acetilmetadol | 3-acetoxy-6-dimethylamino-4,4-diphenylheptane |
| 4 | 醋托啡 | Acetorfina | 3-O-acetyltetrahydro-7α-(1-hydroxy-1-methylbutyl)-6,14-endo-ethenooripavine |
| 5 | 阿醋美沙朵 | Alfacetilmetadol | α-3-acetoxy-6-dimethylamino-4,4-diphenylheptane |
| 6 | 阿法美羅定 | Alfameprodina | α-3-ethyl-1-methyl-4-phenyl-4-propionoxypiperidine |
| 7 | 阿法美沙朵 | Alfametadol | α-6-dimethylamino-4,4-diphenyl-3-heptanol |
| 8 | 阿法甲基芬太尼 | alfa-Metilfentanil | N-[1-(α-methylphenethyl)-4-piperidyl]propionanilide |
| 9 | 阿法甲基硫代芬太尼 | alfa-Metiltiofentanil | N-{1-[1-methyl-2-(2-thienyl)ethyl]-4-piperidyl}propionanilide |
| 10 | 阿法羅定 | Alfaprodina | α-1,3-dimethyl-4-phenyl-4-propionoxypiperidine |
| 11 | 阿芬太尼 | Alfentanil | N1-[2-(4-ethyl-4,5-dihydro-5-oxo-1H-tetrazol-1-yl)ethyl]-4-(methoxymethyl)-4-piperidinylN-phenylpropanamide |
| 12 | 烯丙羅定 | Alilprodina | 3-allyl-1-methyl-4-phenyl-4-propionoxypiperidine |
| 13 | 阿尼利定 | Anileridina | 1-p-aminophenethyl-4-phenylpiperidine-4-carboxylic acid ethyl ester |
| 14 | 苄替啶 | Benzetidina | 1-(2-benzyloxyethyl)-4-phenylpiperidine-4-carboxylic acid ethyl ester |
| 15 | 苄嗎啡 | Benzilmorfina | 3-benzylmorphine |
| 16 | 倍醋美沙朵 | Betacetilmetadol | β-3-acetoxy-6-dimethylamino-4,4-diphenylheptane |
| 17 | 倍他羥基芬太尼 | beta-Hidroxifentanil | N-[1-(β-hydroxyphenethyl)-4-piperidyl]propionanilide |
| 18 | 倍他羥基-3-甲基芬太尼 | beta-Hidroxi-3-metilfentanil | N-[1-(β-hydroxyphenethyl)-3-methyl-4-piperidyl]propionanilide |
| 19 | 倍他美羅定 | Betameprodina | β-3-ethyl-1-methyl-4-phenyl-4-propionoxypiperidine |
| 20 | 倍他美沙朵 | Betametadol | β-6-dimethylamino-4,4-diphenyl-3-heptanol |
| 21 | 倍他羅定 | Betaprodina | β-1,3-dimethyl-4-phenyl-4-propionoxypiperidine |
| 22 | 貝齊米特 | Bezitramida | 1-(3-cyano-3,3-diphenylpropyl)-4-(2-oxo-3-propionyl-1-benzimidazolinyl)piperidine |
| 23 | 嗎苯丁酯 | Butirato de dioxafetilo | ethyl-4-morpholino-2,2-diphenylbutyrate |
| 24 | 凱托米酮 | Cetobemidona | 4-m-hydroxyphenyl-1-methyl-4-propionylpiperidine |
| 25 | 氯尼他秦 | Clonitazeno | 2-(p-chlorobenzyl)-1-diethylaminoethyl-5-nitrobenzimidazole |
| 26 | 可待因 | Codeína | 3-methylmorphine |
| 27 | 可待因-N-氧化物 | Codeína-N-óxido | morphinan-6-ol, 7,8-didehydro-4,5-epoxy-3-methoxy-17-methyl-, 17-oxide |
| 28 | 可多克辛 | Codoxina | dihydrocodeinone-6-carboxymethyloxime |
| 29 | 罌粟稈濃縮物
- 是富含嗎啡、可待因、蒂巴因、奧列巴文或那可丁的五種罌粟稈中的任何一種進入生物鹼濃縮過程時產生的中間材料 |
Concentrado de palha de papoila
- É o produto intermédio obtido quando qualquer das cinco variedades de palha de papoila ricas em morfina, codeína, tebaína, oripavina ou noscapina é submetida a um processo de concentração de alcalóides |
|
| 30 | 地索嗎啡 | Desomorfina | dihydrodesoxymorphine |
| 31 | 右嗎拉胺 | Dextromoramida | (+)-4-[2-methyl-4-oxo-3,3-diphenyl-4-(1-pyrrolidinyl)butyl]morpholine |
| 32 | 右丙氧芬 | Dextropropoxifeno | α-(+)-4-dimethylamino-1,2-diphenyl-3-methyl-2-butanol propionate |
| 33 | 地恩丙胺 | Diampromida | N-[2-(methylphenethylamino)-propyl]propionanilide |
| 34 | 二乙噻丁 | Dietiltiambuteno | 3-diethylamino-1,1-di-(2’-thienyl)-1-butene |
| 35 | 地芬諾酯 | Difenoxilato | 1-(3-cyano-3,3-diphenylpropyl)-4-phenylpiperidine-4-carboxylic acid ethyl ester |
| 36 | 地芬諾辛 | Difenoxina | 1-(3-cyano-3,3-diphenylpropyl)-4-phenylisonipecotic acid |
| 37 | 雙氫可待因 | Diidrocodeína | (5α,6α)-4,5-epoxy-3-methoxy-17-methylmorphinan-6-ol |
| 38 | 二氫埃托啡 | Diidroetorfina | 7,8-dihydro-7α-[1-(R)-hydroxy--1-methylbutyl]-6,14-endo-ethanotetrahydrooripavine |
| 39 | 雙氫嗎啡 | Di-hidromorfina | (5α,6α)-4,5-epoxy-17-methylmorphinan-3,6-diol |
| 40 | 地美庚醇 | Dimefeptanol | 6-dimethylamino-4,4-diphenyl-3-heptanol |
| 41 | 地美沙朵 | Dimenoxadol | 2-dimethylaminoethyl-1-ethoxy-1,1-diphenylacetate |
| 42 | 二甲噻丁 | Dimetiltiambuteno | 3-dimethylamino-1,1-di-(2’-thienyl)-1-butene |
| 43 | 地匹哌酮 | Dipipanona | 4,4-diphenyl-6-piperidine-3-heptanone |
| 44 | 羥蒂巴酚 | Drotebanol | 3,4-dimethoxy-17-methylmorphinan-6β,14-diol |
| 45 | 乙甲噻丁 | Etilmetiltiambuteno | 3-ethylmethylamino-1,1-di-(2’-thienyl)-1-butene |
| 46 | 乙基嗎啡 | Etilmorfina | 3-ethylmorphine |
| 47 | 依托尼秦 | Etonitazeno | 1-diethylaminoethyl-2-p-ethoxybenzyl-5-nitrobenzimidazole |
| 48 | 埃托啡 | Etorfina | tetrahydro-7α-(1-hydroxy-1-methylbutyl)-6,14-endo-ethenooripavine |
| 49 | 依托利定 | Etoxeridina | 1-[2-(2-hydroxyethoxy)-ethyl]-4-phenylpiperidine-4-carboxylic acid ethyl ester |
| 50 | 苯嗎庚酮 | Fenadoxona | 6-morpholino-4,4-diphenyl-3-heptanone |
| 51 | 非那丙胺 | Fenanpromida | N-(1-methyl-2-piperidinoethyl)propionanilide |
| 52 | 非那佐辛 | Fenazocina | 2’-hydroxy-5,9-dimethyl-2-phenethyl-6,7-benzomorphan |
| 53 | 非諾啡烷 | Fenomorfano | 3-hydroxy-N-phenethylmorphinan |
| 54 | 苯哌利定 | Fenopiridina | 1-(3-hydroxy-3-phenylpropyl)-4-phenylpiperidine-4-carboxylic acid ethyl ester |
| 55 | 芬太尼 | Fentanil | 1-phenethyl-4-N-propionylanilinopiperidine |
| 56 | 福爾可定 | Folcodina | morpholinylethylmorphine |
| 57 | 呋替啶 | Furetidina | 1-(2-tetrahydrofurfuryloxyethyl)-4-phenylpiperidine-4-carboxylic acid ethyl ester |
| 58 | 海洛因 | Heroína | diacetylmorphine |
| 59 | 氫可酮 | Hidrocodona | dihydrocodeinone |
| 60 | 氫嗎啡醇 | Hidromorfinol | 14-hydroxydihydromorphine |
| 61 | 氫嗎啡酮 | Hidromorfona | dihydromorphinone |
| 62 | 羥哌替啶 | Hidroxipetidina | 4-m-hydroxyphenyl-1-methylpiperidine-4-carboxylic acid ethyl ester |
| 63 | 異美沙酮 | Isometadona | 6-dimethylamino-5-methyl-4,4-diphenyl-3-hexanone |
| 64 | 左芬啡烷 | Levofenacilmorfano | (–)-3-hydroxy-N-phenacylmorphinan |
| 65 | 左美沙芬* | Levometorfano* | (–)-3-methoxy-N-methylmorphinan |
| 66 | 左嗎拉胺 | Levomoramide | (–)-4-[2-methyl-4-oxo-3,3-diphenyl-4-(1-pyrrolidinyl)butyl]morpholine |
| 67 | 左啡諾* | Levorfanol* | (–)-3-hydroxy-N-methylmorphinan |
| 68 | 美沙酮 | Metadona | 6-dimethylamino-4,4-diphenyl-3-heptanone |
| 69 | 美沙酮中間體 | Metadona, intermediário de | 4-cyano-2-dimethylamino-4,4-diphenylbutane |
| 70 | 美他佐辛 | Metazocina | 2’-hydroxy-2,5,9-trimethyl-6,7-benzomorphan |
| 71 | 甲地索啡 | Metildesorfina | 6-methyl-Δ6-deoxymorphine |
| 72 | 甲二氫嗎啡 | Metildiidromorfina | 6-methyldihydromorphine |
| 73 | 3-甲基芬太尼 | 3-metilfentanil | N-(3-methyl-1-phenethyl-4-piperidyl)propionanilide |
| 74 | 3-甲基硫代芬太尼 | 3-metiltiofentanil | N-{3-methyl-1-[2-(2-thienyl)ethyl]-4-piperidyl}propionanilide |
| 75 | 美托酮 | Metopão | 5-methyldihydromorphinone |
| 76 | 麥羅啡 | Mirofina | myristylbenzylmorphine |
| 77 | 嗎拉胺中間體 | Moramida, intermediário de | 2-methyl-3-morpholino-1,1-diphenylpropane carboxylic acid |
| 78 | 嗎哌利定 | Morferidina | 1-(2-morpholinoethyl)-4-phenylpiperidine-4-carboxylic acid ethyl ester |
| 79 | 嗎啡 | Morfina | (5α,6α)-7,8-didehydro-4,5-epoxy-17-methylmorphinan-3,6-diol |
| 80 | 嗎啡甲溴化物（和其他五價氮嗎啡衍生物，特别包括嗎啡-N-氧化物的衍生物，其中一種是可待因-N-氧化物） | Bromometilato de morfina (e outros derivados da morfina com azoto pentavalente, incluindo particularmente derivados de N-óxido de morfina, entre os quais N-óxido de codeína) | |
| 81 | 嗎啡-N-氧化物 | Morfina-N-óxido | (5α,6α)-7,8-didehydro-4,5-epoxy-17-methylmorphinan-3,6-diol-17-oxide |
| 82 | 1-甲基-4-苯基-4-哌啶丙酸酯 | MPPP | 1-methyl-4-phenyl-4-piperidinol propionate (ester) |
| 83 | 尼可待因 | Nicocodina | 6-nicotinylcodeine |
| 84 | 尼可嗎啡 | Nicomorfina | 3,6-dinicotinylmorphine |
| 85 | 尼二氫可待因 | Nicodicodina | 6-nicotinyldihydrocodeine |
| 86 | 諾美沙朵 | Noracimetadol | (±)-α-3-acetoxy-6-methylamino-4,4-diphenylheptane |
| 87 | 去甲可待因 | Norcodeína | N-demethylcodeine |
| 88 | 去甲左啡諾 | Norlevorfanol | (–)-3-hydroxymorphinan |
| 89 | 去甲美沙酮 | Normetadona | 6-dimethylamino-4,4-diphenyl-3-hexanone |
| 90 | 去甲嗎啡 | Normorfina | demethylmorphine |
| 91 | 諾匹哌酮 | Norpipanona | 4,4-diphenyl-6-piperidino-3-hexanone |
| 92 | 阿片
- 罌粟汁凝固物（植物物種：Papaver somniferum L.） |
Ópio
- O suco coagulado da papoila de ópio (espécie de planta: Papaver somniferum L.) |
|
| 93 | 阿片
- 多種生物鹼的氯化物及溴化物的混合物 |
Ópio
- Mistura de alcalóides sob a forma de cloridratos e brometos |
|
| 94 | 羥考酮 | Oxicodona | 14-hydroxydihydrocodeinone |
| 95 | 羥嗎啡酮 | Oximorfona | 14-hydroxydihydromorphinone |
| 96 | 對氟代芬太尼 | para-Fluorofentanil | 4’-fluoro-N-(1-phenethyl-4-piperidyl)propionanilide |
| 97 | 1-苯乙基-4-苯基-4-哌啶乙酸酯 | PEPAP | 1-phenethyl-4-phenyl-4-piperidinol acetate (ester) |
| 98 | 哌替啶 | Petidina | 1-methyl-4-phenylpiperidine-4-carboxylic acid ethyl ester |
| 99 | 哌替啶中間體A | Petidina, intermediário A da | 4-cyano-1-methyl-4-phenylpiperidine |
| 100 | 哌替啶中間體B | Petidina, intermediário B da | 4-phenylpiperidine-4-carboxylic acid ethyl ester |
| 101 | 哌替啶中間體C | Petidina, intermediário C da | 1-methyl-4-phenylpiperidine-4-carboxylic acid |
| 102 | 匹米諾定 | Piminodina | 4-phenyl-1-(3-phenylaminopropyl)piperidine-4-carboxylic acid ethyl ester |
| 103 | 哌腈米特 | Piritramida | 1-(3-cyano-3,3-diphenylpropyl)-4-(1-piperidino)piperidine-4-carboxylic acid amide |
| 104 | 普羅庚嗪 | Pro-heptazina | 1,3-dimethyl-4-phenyl-4-propionoxyazacycloheptane |
| 105 | 丙哌利定 | Properidina | 1-methyl-4-phenylpiperidine-4-carboxylic acid isopropyl ester |
| 106 | 丙吡胺 | Propirano | N-(1-methyl-2-piperidinoethyl)-N-2-pyridylpropionamide |
| 107 | 消旋甲啡烷 | Racemétorfano | (±)-3-methoxy-N-methylmorphinan |
| 108 | 外消旋嗎拉胺 | Racemoramida | (±)-4-[2-methyl-4-oxo-3,3-diphenyl-4-(1-pyrrolidinyl)butyl]morpholine |
| 109 | 消旋啡烷 | Racemorfano | (±)-3-hydroxy-N-methylmorphinan |
| 110 | 瑞芬太尼 | Remifentanilo | 1-(2-methoxycarbonylethyl)-4- (phenylpropionylamino)-piperidine-4- carboxylic acid methyl ester |
| 111 | 舒芬太尼 | Sufentanil | N-{4-(methoxymethyl)-1-[2-(2-thienyl)ethyl]-4-piperidyl}propionanilide |
| 112 | 醋氫可酮 | Tabecão | acetyldihydrocodeinone |
| 113 | 蒂巴因 | Tebaína | (5α)-6,7,8,14-tetradehydro-4,5-epoxy-3, 6-dimethoxy-17-methylmorphinan |
| 114 | 替利定 | Tilidina | (±)-ethyl-trans-2-(dimethylamino)-1-phenyl-3-cyclohexene-1-carboxylate |
| 115 | 硫代芬太尼 | Tiofentanil | N-{1-[2-(2-thienyl)ethyl]-4-piperidyl}propionanilide |
| 116 | 三甲利定 | Trimeperidina | 1,2,5-trimethyl-4-phenyl-4-propionoxypiperidine |
| 117 | AH-7921 | AH-7921 | 3,4-dichloro-N-{[1-(dimethylamino)cyclohexyl]methyl}benzamide |
| 118 | 乙酰芬太尼 | Acetylfentanyl | N-phenyl-N-[1-(2-phenylethyl)-4-piperidinyl]acetamide |
| 119 | MT-45 | MT-45 | 1-cyclohexyl-4-(1,2-diphenylethyl)piperazine |
| 120 | U-47700 | U-47700 | 3,4-dichloro-N-(2-dimethylamino-cyclohexyl)-N-methyl-benzamide |
| 121 | 丁苯芬 | Butyrfentanyl | N-phenyl-N-[1-(2-phenylethyl)-4-piperidinyl]butanamide |
| 122 | 卡芬太尼 | Carfentanil | methyl 1-(2-phenylethyl)-4-[phenyl(propanoyl)amino]piperidine-4-carboxylate |
| 123 | 奧芬太尼 | Ocfentanil | N-(2-fluorophenyl)-2-methoxy-N-[1-(2-phenylethyl)piperidin-4-yl]acetamide |
| 124 | 呋喃芬太尼 | Furanylfentanyl | N-phenyl-N-[1-(2-phenylethyl)piperidin-4-yl]furan-2-carboxamide |
| 125 | 丙烯酰芬太尼 | Acryloylfentanyl, Acrylfentanyl | N-phenyl-N-[1-(2-phenylethyl)piperidin-4-yl]prop-2-enamide |
| 126 | 4-氟異丁基芬太尼 | 4-Fluoroisobutyrfentanyl, 4-FIBF, pFIBF | N-(4-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)isobutyramide |
| 127 | 四氫呋喃芬太尼 | Tetrahydrofuranylfentanyl, THF-F | N-phenyl-N-[1-(2-phenylethyl)piperidin-4-yl]tetrahydrofuran-2-carboxamide |
| 128 | 對氟丁酰芬太尼 | Parafluorobutyrylfentanyl | N-(4-fluorophenyl)-N-[1-(2-phenylethyl)piperidin-4-yl]butanamide |
| 129 | 甲氧基乙酰芬太尼 | Methoxyacetylfentanyl | 2-methoxy-N-phenyl-N-[1-(2-phenylethyl)piperidin-4-yl]acetamide |
| 130 | 環丙基芬太尼 | Cyclopropylfentanyl | N-phenyl-N-[1-(2-phenylethyl)piperidin-4-yl]cyclopropanecarboxamide |
| 131 | 巴豆酰芬太尼 | Crotonylfentanyl | (E)-N-(1-phenethylpiperidin-4-yl)-N-phenylbut-2-enamide |
| 132 | 戊酰芬太尼 | Valerylfentanyl | N-(1-phenethylpiperidin-4-yl)-N-phenylpentanamide |
| 133 | 奧列巴文 | Oripavina | 3-O-demethylthebaine |
| 134 | 鄰氟芬太尼 | Orthofluorofentanyl | N-(2-fluorophenyl)-N-[1-(2-phenylethyl)piperidin-4-yl]propanamide |
| 135 | 異硝氮烯 | Isotonitazene | N,N-diethyl-2-[2-(4-isopropoxybenzyl)-5--nitro-1H-benzo[d]imidazol-1-yl]ethan-1-amine |
| 136 | 溴啡 | Brorphine | 11-[1-(4-bromophenyl)ethyl]-piperidin-4-yl1,3-dihydro-2H-benzimidazol-2-one |
| 137 | 甲硝苯 | Metonitazene | N,N-diethyl-2-[2-(4-methoxybenzyl)-5-nitro-1H-benzo[d]imidazol-1-yl]ethan-1-amine |
| 列於本附表內物質在其特定化學名稱下可能存在的異構體，但明確不列入本附表的異構體除外。 | |||
| 列於本附表內物質的各形式酯類及醚類，但不包括列於其他附表的酯類及醚類。 | |||
| 列於本附表內物質的鹽類，包括上述酯類、醚類及異構體的鹽類，只要該等鹽類的形式屬可能。 | |||
| *右美沙芬及右啡烷均明確不列入本附表內。 |
表一 B
| 編號 | 中文名稱 | 葡文名稱 | 化學名稱∕結構 |
|---|---|---|---|
| 1 | 古柯葉
- 古柯樹（紅木屬genus Erythroxylon的任何一種植物）的葉，已提取所有芽子鹼、可卡因和任何其他芽子鹼生物鹼的葉除外 |
Coca, folha de
- folha de arbustos de coca (toda a espécie de arbustos do género Erythroxylon), com a excepção da folha donde hajam sido retirados toda a ecgonina, a cocaína e qualquer outro alcalóide ecgnonínico|| | |
| 2 | 可卡因 | Cocaína | methyl ester of benzoylecgonine |
| 3 | 可卡因-D
- 可卡因的右旋異構體 |
Cocaína-D
- isómero dextrógiro de cocaína |
|
| 4 | 芽子鹼
- 及其酯類及可轉變為芽子鹼及可卡因的衍生物 |
Ecgonina
- e os seus ésteres e derivados que sejam convertíveis em ecgonina e cocaína |
|
| 本附表所列複合物的所有可能存在的鹽類，均視為列入本附表內。 |
表一 C
| 編號 | 中文名稱 | 葡文名稱 | 化學名稱∕結構 |
|---|---|---|---|
| 1 | 大麻
- Cannabis sativa L.植物的葉，或其開花或結果的頂部，但並未從中提取出不論被冠以何種名稱的樹脂者 |
Canabis
- folhas ou sumidades floridas ou frutificadas da planta Cannabis sativa L. da qual não se tenha extraído a resina, qualquer que seja a denominação que se lhe dê |
|
| 2 | 大麻樹脂
- 從大麻（Cannabis）植物取得的，未經提煉或已提純的分離樹脂 |
Canabis, resina de
- resina separada, em bruto ou purificada, obtida a partir da planta Cannabis |
|
| 3 | 大麻油
- 從大麻（Cannabis）植物取得的，未經提煉或已提純的分離油類 |
Canabis, óleo de
- óleo separado, em bruto ou purificado, obtido a partir da planta Cannabis |
|
| 本附表所列複合物的所有可能存在的鹽類，均視為列入本附表內。 |
表二 A
| 編號 | 中文名稱 | 葡文名稱 | 化學名稱∕結構 |
|---|---|---|---|
| 1 | 2,5-二甲氧基-4-溴苯己胺 | 2C-B | 4-bromo-2,5-dimethoxyphenethylamine |
| 2 | 2,5-二甲氧基-4-丙硫基苯乙胺 | 2C-T-7 | 4-propylthio-2,5-dimethoxyphenethylamine |
| 3 | 蟾酥鹼 | Bufotenina | 3-[2-(Dimethylamino)ethyl]-1H-indol-5-ol |
| 4 | 卡西酮 | Catinona | (–)-(S)-2-aminopropiophenone |
| 5 | 二乙基色胺 | DET | 3-[2-(diethylamino)ethyl]indole |
| 6 | 二甲氧基苯丙胺 | DMA | (±)-2,5-dimethoxy-α-methylphenethylamine |
| 7 | (1,2-二甲基庚基)羥基四氫甲基二苯吡喃 | DMHP | 3-(1,2-dimethylheptyl)-7,8,9,10-tetrahydro-6,6,9-trimethyl-6H-dibenzo[b,d]pyran-1-ol |
| 8 | 二甲基色胺 | DMT | 3-[2-(dimethylamino)ethyl]indole |
| 9 | 布苯丙胺 | Brolanfetamina, DOB | (±)-4-bromo-2,5-dimethoxy-α-methylphenethylamine |
| 10 | 二甲氧基乙基苯丙胺 | DOET | (±)-4-ethyl-2,5-dimethoxy-α-phenethylamine |
| 11 | 二甲氧基甲苯異丙胺 | STP, DOM | 2,5-dimethoxy-α,4-dimethylphenethylamine |
| 12 | 二丙色胺 | DPT | N,N-dipropyltryptamine |
| 13 | 乙環利定 | Eticiclidina, PCE | N-ethyl-1-phenylcyclohexylamine |
| 14 | 乙色胺 | Etriptamina | 3-(2-aminobutyl)indole |
| 15 | 苯環利定 | Fenciclidina, PCP | 1-(1-phenylcyclohexyl)piperidine |
| 16 | 麥角二乙胺，致幻劑，致幻劑-25 | Lisergida, LSD, LSD-25 | 9,10-didehydro-N,N-diethyl-6-methylergoline-8β-carboxamide |
| 17 | 替苯丙胺 | Tenanfetamina, MDA | α-methyl-3,4-(methylenedioxy)phenethylamine |
| 18 | 亞甲二氧基甲基苯丙胺 | MDMA | (±)-N,α-dimethyl-3,4-(methylenedioxy)phenethylamine |
| 19 | 甲羥芬胺 | MMDA | 5-methoxy-α-methyl-3,4-(methylenedioxy)phenethylamine |
| 20 | 麥司卡林 | Mescalina | 3,4,5-trimethoxyphenethylamine |
| 21 | 甲米雷司 | 4-Metilaminorex | (±)-cis-2-amino-4-methyl-5-phenyl-2-oxazoline |
| 22 | 甲卡西酮 | Metilcatinona | 2-(methylamino)-1-phenylpropan-1-one |
| 23 | 4-甲硫苯丙胺 | 4-MTA | α-methyl-4-methylthiophenethylamine |
| 24 | 乙芬胺 | N-etil MDA, MDE | (±)-N-ethyl-α-methyl-3,4-(methylenedioxy)phenethylamine |
| 25 | 羥芬胺 | N-hidroxi MDA | (±)-N-[α-methyl-3,4-(methylenedioxy)phenethyl]hydroxylamine |
| 26 | 六氫大麻酚 | Para-hexilo | 3-hexyl-7,8,9,10-tetrahydro-6,6,9-trimethyl-6H-dibenzo[b,d]pyran-1-ol |
| 27 | PMA | PMA | p-methoxy-α-methylphenethylamine |
| 28 | 副甲氧基甲基苯丙胺 | PMMA | Paramethoxymethylamphetamine(=N-methyl-1-(4-methoxyphenyl)-2-aminopropane) |
| 29 | 賽洛西賓 | Psilocibina | 3-[2-(dimethylamino)ethyl]indol-4-yl dihydrogen phosphate |
| 30 | 賽洛新 | Psilocina, Psilotsin | 3-[2-(dimethylamino)ethyl]indol-4-ol |
| 31 | 咯環利定 | Roliciclidina, PHP, PCPY | 1-(1-phenylcyclohexyl)pyrrolidine |
| 32 | 替諾環定 | Tenociclidina, TCP | 1-[1-(2-thienyl)cyclohexyl]piperidine |
| 33 | 三甲氧基苯丙胺 | TMA | (±)-3,4,5,-trimethoxy-α-methylphenethylamine |
| 34 | 卡西酮的衍生物* （不包括已列於各附表的物質） - 任何在結構上可從2-氨基-1-苯基-1-丙酮通過以下任何方式衍生成的化合物： （1）在苯環上以不限數量的烷基、烷氧基、亞烷二氧基、鹵代烷基或鹵素取代，而不論生成物有否再在苯環上被一個或多個的單價取代基所取代； （2）在3-位上以烷基取代； （3）在氮原子上以烷基、雙烷基取代，或把氮原子納入一個環狀結構。 - 任何在結構上可從2-氨基-1-丙酮的1-位上以各種單環或稠環（不包括苯環或亞烷二氧苯環）衍生成的化合物，不論其有否再用以下任何方式作取代： （1）在單環或稠環上以不限數量的烷基、烷氧基、鹵代烷基或鹵素取代，而不論生成物有否再在環上被一個或多個的單價取代基所取代； （2）在3-位上以烷基取代； （3）在2-氨基的氮原子上以烷基或雙烷基取代，或把2-氨基的氮原子納入一個環狀結構。 |
Derivados da Catinona* (salvo se as substâncias figurarem noutra tabela) - Qualquer composto derivado estruturalmente da 2-amino-1-phenyl-1-propanone por modificação de qualquer das seguintes formas: (1) por substituição de qualquer extensão no anel fenil pelos substituintes alcoíl, alcóxi, alquillenedioxi, haloalquil ou haleto, quer seja ou não ainda mais substituída no anel fenil por um ou mais substituintes univalentes; (2) por substituição na posição-3 com um substituinte alcoíl; (3) por substituição no átomo de azoto com os grupos alcoíl ou dialcoíl, ou por inclusão do átomo de azoto numa estrutura cíclica. - Qualquer composto derivado estruturalmente da 2-aminopropan-1-one por substituição na posição-1 por qualquer sistema anelar monocíclico, ou policíclicos-fundidos (sem ser um sistema anelar fenil ou alquillenedioxifenil), se o composto é ou não: (1) por substituição de qualquer extensão no sistema anelar monocíclico, ou policíclicos-fundidos com substituintes alcoíl, alcóxi, haloalquil ou haleto, quer seja ou não ainda mais substituída no sistema anelar por um ou mais substituintes univalentes; (2) por substituição na posição-3 por qualquer substituinte alcoíl; (3) por substituição do átomo 2-amino nitrogen pelos grupos alcoíl ou dialcoíl ou por inclusão do átomo 2-amino nitrogen numa estrutura cíclica. |
|
| 35 | 哌嗪的衍生物
- 1-苄基哌嗪 - 任何在結構上可從1-苄基哌嗪或1-苯基哌嗪通過以下任何方式衍生成的化合物： （1）在哌嗪環的第2位氮原子上以烷基、苄基、鹵代烷基或苯基取代； （2）在芳香環上以不限數量的烷基、烷氧基、亞烷二氧基、鹵基或鹵代烷基取代。 |
Derivados da Piperazina
- 1-Benzilpiperazina - Qualquer composto estruturalmente derivado da 1-benzilpiperazina ou 1-fenilpiperazina por modificação de qualquer das seguintes maneiras: (1) por substituição do segundo átomo de azoto no anel piperazina com os grupos alcoíl, benzil, haloalquíl ou fenil; (2) por substituição em qualquer extensão do anel aromático com os grupos alcoíl, alcóxi alquilenedioxi, haleto ou haloalquil. |
|
| 36 | 墨西哥鼠尾草 -Salvia Divinorum植物 |
Salvia divinorum | |
| 37 | 丹酚-A | Salvinorina-A | (2S, 4aR, 6aR, 7R, 9S, 10aS, 10bR)-9-(acetyloxy)-2-(3-furanyl) dodecahydro-6a, 10b-dimethyl-4, 10-dioxo-2H-naphtho [2,1-c] pyran-7-carboxylic acid methyl ester |
| 38 | 25B-NBOMe | 25B-NBOMe | 2-(4-bromo-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl)ethanamine |
| 39 | 25C-NBOMe | 25C-NBOMe | 2-(4-chloro-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl)ethanamine |
| 40 | 25I-NBOMe | 25I-NBOMe | 2-(4-iodo-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl)ethanamine |
| 41 | 副甲基甲米雷司 | para-Methyl-4-methylami norex, 4,4’-DMAR | para-methyl-4-methylaminorex |
| 42 | DOC | DOC | 4-chloro-2,5-dimethoxyamfetamine |
| 43 | 3-甲氧基苯環利定 | 3-Methoxyphencyclidine | 1-[1-(3-methoxyphenyl)cyclohexyl]piperidine |
| 44 | 二苯基乙基哌啶 | Diphenidine | 1-(1,2-diphenylethyl)piperidine |
| 列於本附表內物質的可能存在的鹽類。 | |||
| 列於本附表內物質在其特定化學名稱下可能存在的異構體，但明確不列入本附表的異構體除外。 | |||
| *卡西酮的衍生物中，安非他酮明確地不列入本表內。 |
表二 B
| 編號 | 中文名稱 | 葡文名稱 | 化學名稱∕結構 |
|---|---|---|---|
| 1 | 安咪奈丁 | Amineptina | 7-[(10,11-dihydro-5H-dibenzo[a,d]cyclohepten-5-yl)amino]heptanoic acid |
| 2 | 苯丙胺 | Anfetamina | (±)-α-methylphenethylamine |
| 3 | 去甲偽麻黃鹼，(+)-降偽麻黃鹼 | Catina, (+)-Norpseudoefedrina | (+)-(S)-α-[(S)-1-aminoethyl]benzyl alcohol |
| 4 | 右苯丙胺 | Dexanfetamina | (+)-α-methylphenethylamine |
| 5 | 屈大麻酚， ∆-9-四氫大麻酚及其立體化學變體 | Dronabinol, delta-9-Tetraidrocanabinol e seus variantes estereoquímicos | (6aR,10aR)-6a,7,8,10a-tetrahydro-6,6,9-trimethyl-3-pentyl-6H-dibenzo[b,d]pyran-1-ol |
| 6 | 苯甲曲秦 | Fendimetrazina | (+)-(2S,3S)-3,4-dimethyl-2-phenylmorpholine |
| 7 | 芬乙茶鹼 | Fenetilina | 7- {2-[(α-methylphenethyl)amino]ethyl} theophylline |
| 8 | 芬美曲秦 | Fenmetrazina | 3-methyl-2-phenylmorpholine |
| 9 | 芬特明 | Fentermina | α,α-dimethylphenethylamine |
| 10 | 左苯丙胺 | Levanfetamina | (–)-(R)-α-methylphenethylamine |
| 11 | 左甲苯丙胺 | Levometanfetamina | (–)-N,α-dimethylphenethylamine |
| 12 | 甲基苯丙胺 | Metanfetamina | (+)-(S)-N,α-dimethylphenethylamine |
| 13 | 甲基苯丙胺外消旋體 | Racemato de metanfetamina | (±)-N,α-dimethylphenethylamine |
| 14 | 哌醋甲酯 | Metilfenidato | methyl α-phenyl-2-piperidine acetate |
| 15 | N,N-二甲基安非他明 | N,N-dimetanfetamina | N,N-dimethylamphetamine |
| 16 | 四氫大麻酚 - 下列同分異構體及其立體化學變體 |
Tetraidrocanabinol - os isómeros e seus variantes estereoquímicos abaixo indicados | |
| delta-6a(10a)-THC | delta-6a(10a)-THC | 7,8,9,10-tetrahydro-6,6,9-trimethyl-3-pentyl-6H-dibenzo[b,d]pyran-1-ol | |
| delta-6a(7)-THC | delta-6a(7)-THC | (9R,10aR)-8,9,10,10a-tetrahydro-6,6,9-trimethyl-3-pentyl-6H-dibenzo[b,d]pyran-1-ol | |
| delta-7-THC | delta-7-THC | (6aR,9R,10aR)-6a,9,10,10a-tetrahydro-6,6,9-trimethyl-3-pentyl-6H-dibenzo[b,d]pyran-1-ol | |
| delta-8-THC | delta-8-THC | (6aR,10aR)-6a,7,10,10a-tetrahydro-6,6,9-trimethyl-3-pentyl-6H-dibenzo[b,d]pyran-1-ol | |
| delta-10-THC | delta-10-THC | 6a,7,8,9-tetrahydro-6,6,9-trimethyl-3-pentyl-6H-dibenzo[b,d]pyran-1-ol | |
| delta-9(11)-THC | delta-9(11)-THC | (6aR,10aR)-6a,7,8,9,10,10a-hexahydro-6,6-dimethyl-9-methylene-3-pentyl-6H-dibenzo[b,d]pyran-1-ol | |
| 17 | 齊培丙醇 | Zipeprol | α-(α-methoxybenzyl)-4-(β-methoxyphenethyl)--1-piperazineethanol |
| 18 | 合成大麻素
- 任何在結構上可從3-(1-萘甲酰基)吲哚或1H-吲哚-3-基-1-萘甲烷通過在吲哚環的氮原子上以烷基、鏈烯基、環烷甲基、環烷乙基或2-(4-嗎啉基)乙基取代所生成的化合物，而不論生成物有否再在吲哚環或萘環以不限數量取代 - 任何在結構上可從3-(1-萘甲酰基)吡咯通過在吡咯環的氮原子上以烷基、鏈烯基、環烷甲基、環烷乙基或2-(4-嗎啉基)乙基取代所生成的化合物，而不論生成物有否再在吡咯環或萘環以不限數量取代 - 任何在結構上可從1-(1-萘亞甲基)茚通過在茚環的3-位上以烷基、鏈烯基、環烷甲基、環烷乙基或2-(4-嗎啉基)乙基取代所生成的化合物，而不論生成物有否再在茚環或萘環以不限數量取代 - 任何在結構上可從3-苯乙酰基吲哚通過在吲哚環的氮原子上以烷基、鏈烯基、環烷甲基、環烷乙基或2-(4-嗎啉基)乙基取代所生成的化合物，而不論生成物有否再在吲哚環或苯環以不限數量取代 - 任何在結構上可從2-(3-羥基環己基)酚通過在酚環的5-位上以烷基、鏈烯基、環烷甲基、環烷乙基或2-(4-嗎啉基)乙基取代所生成的化合物，而不論生成物有否再在己基環以不限數量取代 |
Canabinoides sintéticos
- Qualquer composto derivado estruturalmente do 3-(1-naphthoyl)indole ou 1H-indol-3-yl-(1-naphthyl)methane por substituição no átomo de azoto do anel indole por alcoíl, alceno, cicloalcoílmetil, cicloalcoíletil ou 2-(4-morfolinil)etil, quer seja ou não ainda mais substituído em qualquer extensão do anel indole quer seja ou não ainda mais substituído em qualquer extensão do anel naftaleno - Qualquer composto derivado estruturalmente do 3-(1-naphthoyl)pyrrole por substituição no átomo de azoto do anel pirrol por alcoíl, alceno, cicloalcoílmetil, cicloalcoíletil ou 2-(4-morpholinyl)ethyl, quer seja ou não ainda mais substituído em qualquer extensão do anel pirrol, quer seja ou não ainda mais substituído em qualquer extensão do anel naftaleno - Qualquer composto derivado estruturalmente do 1-(1-naphthylmethylene)indene por substituição na posição-3 do anel indeno por alcoíl, alceno, cicloalcoílmetil, cicloalcoíletil ou 2-(4-morpholinyl)ethyl, quer seja ou não ainda mais substituído em qualquer extensão do anel pirrol, quer seja ou não ainda mais substituído em qualquer extensão do anel naphthyl - Qualquer composto derivado estruturalmente do 3-phenylacetylindole por substituição no átomo de azoto do anel indole por alcoíl, alceno, cicloalcoílmetil, cicloalcoíletil ou 2-(4-morpholinyl)ethyl, quer seja ou não ainda mais substituído em qualquer extensão do anel indole e quer seja ou não substituído em qualquer extensão do anel fenil - Qualquer composto derivado estruturalmente do 2-(3-hydroxycyclohexyl)phenol por substituição na posição-5 do anel fenól por alcoíl, alceno, cicloalcoílmetil, cicloalcoíletil ou 2-(4-morpholinyl)ethyl, quer seja ou não ainda mais substituído em qualquer extensão do anel ciclohexil |
|
| 19 | 1-(1-萘甲酰基)-4-戊氧基萘 | CRA-13, CB-13 | naphthalen-1-yl-(4-pentyloxynaphthalen-1-yl)methanone |
| 20 | AM-2201, JWH-2201 | AM-2201, JWH-2201 | [1-(5-fluoropentyl)-1H-indol-3-yl](naphthalen--1-yl)methanone |
| 21 | 哌乙酯 | Ethylphenidate | ethyl 2-phenyl-2-(piperidin-2-yl)acetate |
| 22 | Methiopropamine, MPA | Methiopropamine, MPA | 1-(thiophen-2-yl)-2-methylaminopropane |
| 23 | MDMB-CHMICA | MDMB-CHMICA | methyl 2[1-(cyclohexylmethyl)indole-3-carbonyl]amino3,3-dimethylbutanoate |
| 24 | 5F-APINACA, 5F-AKB-48 | 5F-APINACA, 5F-AKB-48 | N-(adamantan-1-yl)-1-(5-fluoropentyl)-1H-indazole-3-carboxamide |
| 25 | XLR-11 | XLR-11 | [1-(5-fluoropentyl)-1H-indol-3-yl](2,2,3,3-tetramethylcyclopropyl)methanone |
| 26 | N-(1-氨甲酰基-2-甲基丙基)-1-(環己基甲基)-吲唑-3-甲酰胺 | AB-CHMINACA | N-[(2S)-1-amino-3-methyl-oxobutan-2-yl]-1-(cyclohexylmethyl)-1H-indazole-3-carboxamide |
| 27 | 5F-ADB, 5F-MDMB-PINACA | 5F-ADB, 5F-MDMB-PINACA | methyl(2S)-2[1-(fluoropentyl)-1H-indazole--3-carbonyl]amino3,3-dimethylbutanoate |
| 28 | AB-PINACA | AB-PINACA | N-[(2S)-1-amino-3-methyl-1-oxobutan-2-yl]-1-pentyl-1H-indazole-3-carboxamide |
| 29 | UR-144 | UR-144 | (1-pentyl-1H-indol-3-yl)(2,2,3,3-tetramethylcyclopropyl)methanone |
| 30 | 5F-PB-22 | 5F-PB-22 | quinolin-8-yl 1-(5-fluoropentyl)-1H-indole--3-carboxylate |
| 31 | 4-氟苯丙胺 | 4-Fluoroamphetamine, 4-FA | 1-(4-fluorophenyl)propan-2-amine |
| 32 | ADB-FUBINACA | ADB-FUBINACA | N-[(2S)-1-amino-3,3-dimethyl-1-oxobutan-2-yl]-1-[(4-fluorophenyl)methyl]-1H-indazole-3-carboxamide |
| 33 | FUB-AMB, MMB-FUBINACA, AMB-FUBINACA | FUB-AMB, MMB-FUBINACA, AMB-FUBINACA | methyl(2S)-2-({1-[(4-fluorophenyl)methyl]-1H--indazole-3-carbonyl}amino)-3-methylbutanoate |
| 34 | CUMYL-4CN-BINACA | CUMYL-4CN-BINACA | 1-(4-cyanobutyl)-N-(2-phenylpropan-2-yl)-1H-indazole-3-carboxamide |
| 35 | ADB-CHMINACA, MAB-CHMINACA | ADB-CHMINACA, MAB-CHMINACA | N-[(2S)-1-amino-3,3-dimethyl-1-oxobutan-2-yl]-1-(cyclohexylmethyl)-1H-indazole-3-carboxamide |
| 36 | AB-FUBINACA | AB-FUBINACA | N-[(2S)-1-amino-3-methyl-1-oxobutan-2-yl]- -1-[(4-fluorophenyl)methyl]indazole-3-carboxamide |
| 37 | 5F-AMB, 5F-AMB-PINACA 5F-AMB, | 5F-AMB-PINACA | methyl 2-({[1-(5-fluoropentyl)-1H-indazol-3-yl]carbonyl}amino)-3-methylbutanoate |
| 38 | 5F-MDMB-PICA | 5F-MDMB-PICA | methyl(S)-2-[1-(5-fluoropentyl)-1H-indole-3-carboxamido]-3,3-dimethylbutanoate |
| 39 | 4F-MDMB-BINACA | 4F-MDMB-BINACA | methyl(S)-2-[1-(4-fluorobutyl)-1H-indazole-3-carboxamido]-3,3-dimethylbutanoate |
| 40 | CUMYL-PEGACLON | CUMYL-PEGACLON | 5-pentyl-2-(2-phenylpropan-2-yl)-2,5-dihydro-1H-pyrido[4,3-b]indol-1-one |
| 41 | MDMB-4en-PINACA | MDMB-4en-PINACA | methyl 3,3-dimethyl-2-[1-(pent-4-en-1-yl)-1H--indazole-3-carboxamido]butanoate |
| 列於本附表內物質可能存在的衍生物及鹽類，以及由該等物質配有其他不論其作用如何的複合物調製而成的所有製劑。 |
表二 C
| 編號 | 中文名稱 | 葡文名稱 | 化學名稱∕結構 |
|---|---|---|---|
| 1 | 異戊巴比妥 | Amobarbital | 5-ethyl-5-isopentylbarbituric acid |
| 2 | 丁丙諾啡 | Buprenorfina | 21-cyclopropyl-7-α-[(S)-1-hydroxy-1,2,2-trimethylpropyl]-6,14-endo--ethano-6,7,8,14-tetrahydrooripavine |
| 3 | 布他比妥 | Butalbital | 5-allyl-5-isobutylbarbituric acid |
| 4 | 環己巴比妥 | Ciclobarbital | 5-(1-cyclohexen-1-yl)-5-ethylbarbituric acid |
| 5 | γ-羥基丁酸， γ-羥丁酸 | Ácido gama-hidroxibutírico, GHB | γ-hydroxybutyric acid |
| 6 | 格魯米特 | Glutetamida | 2-ethyl-2-phenylglutarimide |
| 7 | 氯胺酮 | Ketamina | (±)-2-(2-chlorophenyl)-2-(methylamino)-cyclohexanone |
| 8 | 甲氯喹酮 | Mecloqualona | 3-(o-chlorophenyl)-2-methyl-4(3H)-quinazolinone |
| 9 | 甲喹酮 | Metaqualona | 2-methyl-3-o-tolyl-4(3H)-quinazolinone |
| 10 | 噴他佐辛 | Pentazocina | (2R*,6R*,11R*)-1,2,3,4,5,6-hexahydro-6,11-dimethyl-3-(3-methyl-2-butenyl)-2,6-methano-3-benzazocin-8-ol |
| 11 | 戊巴比妥 | Pentobarbital | 5-ethyl-5-(1-methylbutyl)barbituric acid |
| 12 | 司可巴比妥 | Secobarbital | 5-allyl-5-(1-methylbutyl)barbituric acid |
| 13 | Methoxetamine, MXE | Methoxetamine, MXE | (RS)-2-(3-methoxyphenyl)-2-(ethylamino)-cyclohexanone |
| 14 | 氟胺酮 | 2-Fluorodeschloroketamine, 2-FDCK | 2-(2-fluorophenyl)-2-(methylamino)cyclohexan-1-one |
| 列於本附表內物質的可能存在的鹽類。 |
表三
| 1 | 製劑：醋氫可待因；可待因；雙氫可待因；乙基嗎啡；福爾可定；尼可待因；尼二氫可待因；去甲可待因。
以上製劑與其他一種或數種成分調配、每劑量單位藥物含量不超過100毫克且其濃度不超過整個製劑的2.5%。 |
| 2 | 丙吡胺製劑：每劑量單位含丙吡胺不超過100毫克並且與至少等量的甲基纖維素相調配。 |
| 3 | 右丙氧芬製劑：口服製劑，其每劑量單位含有不超過135毫克的右丙氧芬鹼或其濃度不超過整個製劑的2.5%，條件是這類製劑不含有根據《一九七一年精神藥物公約》加以管制的任何物品。 |
| 4 | 可卡因製劑：所含可卡因以可卡因鹼計算不超過0.1%；和
阿片或嗎啡製劑：所含嗎啡以無水嗎啡鹼計算不超過0.2%，且因與一種或數種其他成分調配，致使其中的藥物不能以簡便方法回收，或回收的份量不能構成對公眾健康的危害。 |
| 5 | 地芬諾辛製劑：每劑量單位含有不超過0.5毫克的地芬諾辛，並含有至少相當於地芬諾辛劑量5%的硫酸顛茄鹼。 |
| 6 | 地芬諾酯製劑：每劑量單位含有以鹼計算不超過2.5毫克的地芬諾酯，並含有至少相當於地芬諾酯劑量1%的硫酸顛茄鹼。 |
| 7 | 複方阿片吐根散製劑：
10%阿片粉； 10%吐根散； 80%不含任何藥物的其他粉狀成分，細混合。 |
| 8 | 符合本附表所列任一配方的製劑及此製劑與不含任何藥物的原料的混合物。 |
表四
| 編號 | 中文名稱 | 葡文名稱 | 化學名稱∕結構 |
|---|---|---|---|
| 1 | 阿洛巴比妥 | Alobarbital | 5,5-diallylbarbituric acid |
| 2 | 阿普唑侖 | Alprazolam | 8-chloro-1-methyl-6-phenyl-4H-s-triazolo[4,3-a][1,4]benzodiazepine |
| 3 | 安非拉酮，二乙胺苯丙酮 | Amfepramona, Dietilpropiona | 2-(diethylamino)propiophenone |
| 4 | 阿米雷司 | Aminorex | 2-amino-5-phenyl-2-oxazoline |
| 5 | 巴比妥 | Barbital | 5,5-diethylbarbituric acid |
| 6 | 苄非他明， 苯非他明 | Benzefetamina | N-benzyl-N,α-dimethylphenethylamine |
| 7 | 溴西泮 | Bromazepam | 7-bromo-1,3-dihydro-5-(2-pyridyl)-2H-1,4-benzodiazepin-2-one |
| 8 | 溴替唑侖 | Brotizolam | 2-bromo-4-(o-chlorophenyl)-9-methyl-6H-thieno[3,2-f]-s-triazolo[4,3-a][1,4]diazepine |
| 9 | 丁巴比妥 | Butobarbital | 5-butyl-5-ethylbarbituric acid |
| 10 | 卡馬西泮 | Camazepam | 7-chloro-1,3-dihydro-3-hydroxy-1-methyl-5-phenyl-2H-1,4-benzodiazepin-2-one dimethylcarbamate (ester) |
| 11 | 凱他唑侖 | Cetazolam | 11-chloro-8,12b-dihydro-2,8-dimethyl-12b-phenyl-4H-[1,3]oxazino[3,2-d][1,4]benzodiazepin-4,7(6H)-dione |
| 12 | 氯巴占 | Clobazam | 7-chloro-1-methyl-5-phenyl-1H-1,5-benzodiazepine-2,4(3H,5H)-dione |
| 13 | 氯硝西泮 | Clonazepam | 5-(o-chlorophenyl)-1,3-dihydro-7-nitro-2H-1,4-benzodiazepin-2-one |
| 14 | 氯拉卓酸 | Clorazepato | 7-chloro-2,3-dihydro-2-oxo-5-phenyl-1H-1,4-benzodiazepine-3-carboxylic acid |
| 15 | 氯氮卓 | Clordiazepóxido | 7-chloro-2-(methylamino)-5-phenyl-3H-1,4-benzodiazepine-4-oxide |
| 16 | 氯噻西泮 | Clotiazepam | 5-(o-chlorophenyl)-7-ethyl-1,3-dihydro-1-methyl-2H-thieno[2,3-e]-1,4-diazepin-2-one |
| 17 | 氯噁唑侖 | Cloxazolam | 10-chloro-11b-(o-chlorophenyl)-2,3,7,11b-tetrahydrooxazolo-[3,2-d][1,4]benzodiazepin-6(5H)-one |
| 18 | 地洛西泮 | Delorazepam | 7-chloro-5-(o-chlorophenyl)-1,3-dihydro-2H-1,4-benzodiazepin-2-one |
| 19 | 地西泮 | Diazepam | 7-chloro-1,3-dihydro-1-methyl-5-phenyl-2H-1,4-benzodiazepin-2-one |
| 20 | 艾司唑侖 | Estazolam | 8-chloro-6-phenyl-4H-s-triazolo[4,3-a][1,4]benzodiazepine |
| 21 | 乙氯維諾 | Etclorvinol | 1-chloro-3-ethyl-1-penten-4-yn-3-ol |
| 22 | 乙非他明， N-乙基苯丙胺 | Etilanfetamina, N-etilanfetamina | N-ethyl-α-methylphenethylamine |
| 23 | 氯氟卓乙酯 | Etiloflazepato | ethyl 7-chloro-5-(o-fluorophenyl)-2,3-dihydro-2-oxo-1H-1,4-benzodiazepine-3-carboxylate |
| 24 | 炔己蟻胺 | Etinamato | 1-ethynylcyclohexanol carbamate |
| 25 | 芬坎法明 | Fencanfamina | N-ethyl-3-phenyl-2-norbornanamine |
| 26 | 苯巴比妥 | Fenobarbital | 5-ethyl-5-phenylbarbituric acid |
| 27 | 芬普雷斯 | Fenproporex | (±)-3-[(α-methylphenylethyl)amino]propionitrile |
| 28 | 氟地西泮 | Fludiazepam | 7-chloro-5-(o-fluorophenyl)-1,3-dihydro-1-methyl-2H-1,4-benzodiazepin-2-one |
| 29 | 氟硝西泮 | Flunitrazepam | 5-(o-fluorophenyl)-1,3-dihydro-1-methyl-7-nitro-2H-1,4-benzodiazepin-2-one |
| 30 | 氟西泮 | Flurazepam | 7-chloro-1-[2-(diethylamino)ethyl]-5-(o-fluorophenyl)-1,3-dihydro--2H-1,4-benzodiazepin-2-one |
| 31 | 哈拉西泮 | Halazepam | 7-chloro-1,3-dihydro-5-phenyl-1-(2,2,2-trifluoroethyl)-2H-1,4-benzodiazepin-2-one |
| 32 | 鹵沙唑侖 | Haloxazolam | 10-bromo-11b-(o-fluorophenyl)-2,3,7,11b-tetrahydrooxazolo[3,2-d][1,4]benzodiazepin-6(5H)-one |
| 33 | 利非他明 | Lefetamina, SPA | (–)-N,N-dimethyl-1,2-diphenylethylamine |
| 34 | 氯普唑侖 | Loprazolam | 6-(o-chlorophenyl)-2,4-dihydro-2-[(4-methyl-1-piperazinyl)methylene]-8-nitro-1H-imidazo[1,2-a][1,4]benzodiazepin-1-one |
| 35 | 勞拉西泮 | Lorazepam | 7-chloro-5-(o-chlorophenyl)-1,3-dihydro-3-hydroxy-2H-1,4-benzodiazepin-2-one |
| 36 | 氯甲西泮 | Lormetazepam | 7-chloro-5-(o-chlorophenyl)-1,3-dihydro-3-hydroxy-1-methyl-2H-1,4-benzodiazepin-2-one |
| 37 | 馬吲哚 | Mazindol | 5-(p-chlorophenyl)-2,5-dihydro-3H-imidazo[2,1-a]isoindol-5-ol |
| 38 | 美達西泮 | Medazepam | 7-chloro-2,3-dihydro-1-methyl-5-phenyl-1H-1,4-benzodiazepine |
| 39 | 美芬雷斯 | Mefenorex | N-(3-chloropropyl)-α-methylphenethylamine |
| 40 | 甲丙氨酯 | Meprobamato | 2-methyl-2-propyl-1,3-propanediol dicarbamate |
| 41 | 美索卡 | Mesocarbe | 3-(α-methylphenethyl)-N-(phenylcarbamoyl)sydnone imine |
| 42 | 甲苯巴比妥 | Metilfenobarbital | 5-ethyl-1-methyl-5-phenylbarbituric acid |
| 43 | 甲乙哌酮 | Metiprilona | 3,3-diethyl-5-methyl-2,4-piperidine-dione |
| 44 | 咪達唑侖 | Midazolam | 8-chloro-6-(o-fluorophenyl)-1-methyl-4H-imidazo[1,5-a][1,4]benzodiazepine |
| 45 | 尼美西泮 | Nimetazepam | 1,3-dihydro-1-methyl-7-nitro-5-phenyl-2H-1,4-benzodiazepin-2-one |
| 46 | 硝西泮 | Nitrazepam | 1,3-dihydro-7-nitro-5-phenyl-2H-1,4-benzodiazepin-2-one |
| 47 | 去甲西泮 | Nordazepam | 7-chloro-1,3-dihydro-5-phenyl-2H-1,4-benzodiazepin-2-one |
| 48 | 奧沙西泮 | Oxazepam | 7-chloro-1,3-dihydro-3-hydroxy-5-phenyl-2H-1,4-benzodiazepin-2-one |
| 49 | 奧沙唑侖 | Oxazolam | 10-chloro-2,3,7,11b-tetrahydro-2-methyl-11b-phenyloxazolo[3,2-d][1,4]benzodiazepin-6(5H)-one |
| 50 | 匹莫林 | Pemolina | 2-amino-5-phenyl-2-oxazolin-4-one |
| 51 | 匹那西泮 | Pinazepam | 7-chloro-1,3-dihydro-5-phenyl-1-(2-propynyl)-2H-1,4-benzodiazepin--2-one |
| 52 | 哌苯甲醇 | Pipradol | 1,1-diphenyl-1-(2-piperidyl)methanol |
| 53 | 吡咯戊酮 | Pirovalerona | 4’-methyl-2-(1-pyrrolidinyl)valerophenone |
| 54 | 普拉西泮 | Prazepam | 7-chloro-1-(cyclopropylmethyl)-1,3-dihydro-5-phenyl-2H-1,4-benzodiazepin-2-one |
| 55 | 六氫脫氧麻黃鹼 | Propilhexedrina | 1-cyclohexyl-2-methylaminopropane |
| 56 | 仲丁比妥 | Secbutabarbital | 5-sec-butyl-5-ethylbarbituric acid |
| 57 | 替馬西泮 | Temazepam | 7-chloro-1,3-dihydro-3-hydroxy-1-methyl-5-phenyl-2H-1,4-benzodiazepin-2-one |
| 58 | 四氫西泮 | Tetrazepam | 7-chloro-5-(1-cyclohexen-1-yl)-1,3-dihydro-1-methyl-2H-1,4-benzodiazepin-2-one |
| 59 | 三唑侖 | Triazolam | 8-chloro-6-(o-chlorophenyl)-1-methyl-4H-s-triazolo[4,3-a][1,4]benzodiazepine |
| 60 | 乙烯比妥 | Vinilbital | 5-(1-methylbutyl)-5-vinylbarbituric acid |
| 61 | 唑吡旦 | Zolpidem | N,N,6-trimethyl-2-p-tolylimidazo[1,2-a]pyridine-3-acetamide |
| 62 | 芬納西泮 | Phenazepam | 7-bromo-5-(2-chlorophenyl)-1,3-dihydro-2H-1,4-benzodiazepin-2-one |
| 63 | 氟阿普唑侖 | Flualprazolam | 8-chloro-6-(2-fluorophenyl)-1-methyl-4H-benzo[f][1,2,4]triazolo[4,3-a][1,4]diazepine |
| 64 | 依替唑侖 | Etizolam | 4-(2-chlorophenyl)-2-ethyl-9-methyl-6H-thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepine |
| 65 | 氯氮唑侖 | Clonazolam | 6-(2-chlorophenyl)-1-methyl-8-nitro-4H-benzo[f][1,2,4]triazolo[4,3-a][1,4]diazepine |
| 66 | 二氯西泮 | Diclazepam | 7-chloro-5-(2-chlorophenyl)-1-methyl-1,3-dihydro-2H-benzo[e][1,4]diazepin-2-one |
| 67 | 氟溴唑侖 | Flubromazolam | 8-bromo-6-(2-fluorophenyl)-1-methyl-4H-benzo[f][1,2,4]triazolo[4,3-a][1,4]diazepine |
| 列於本附表內物質的可能存在的鹽類。 |
表五
| 編號 | 中文名稱 | 葡文名稱 | 化學名稱∕結構 |
|---|---|---|---|
| 1 | 醋酸酐 | Anidrido acético | acetic oxide |
| 2 | N-乙酰鄰氨基苯酸 | Ácido N-acetilantranílico | benzoic acid, 2-(acetylamino)- |
| 3 | 麻黃鹼 | Efedrina | [R-(R*,S*)]-α-[1-(methylamino)ethyl]benzenemethanol |
| 4 | 麥角新鹼 | Ergometrina | ergoline-8-carboxamide, 9,10-didehydro-N-(2-hydroxy-1- methylethyl)-6-methyl-, [8β(S)] |
| 5 | 麥角胺 | Ergotamina | ergotaman-3’,6’,18’-trione, 12’-hydroxy-2’-methyl-5’-(phenylmethyl)-, (5α) |
| 6 | 異黃樟腦 | Isosafrole | 1,3-benzodioxole, 5-(1-propenyl)- |
| 7 | 麥角酸 | Ácido lisérgico | (8β)-9,10-didehydro-6-methylergoline-8-carboxylic acid |
| 8 | 3,4-亞甲基二氧苯基-2-丙酮 | 3,4-Metilenodioxifenil-2-propanona | 2-propanone, 1-[3,4-(methylenedioxy)phenyl]- |
| 9 | 去甲麻黃鹼 | Norefedrina | (R*,S*)-α-(1-aminoethyl)benzenemethanol |
| 10 | 1-苯基-2-丙酮 | 1-Fenil-2-propanona | 1-phenyl-2-propanone |
| 11 | 胡椒醛 | Piperonal | 1,3-benzodioxole-5-carboxaldehyde |
| 12 | 高錳酸鉀 | Permanganato de potássio | permanganic acid (HMnO4), potassium salt |
| 13 | 偽麻黃鹼 | Pseudoefedrina | [S-(R*,R*)]-α-[1-(methylamino)ethyl]benzenemethanol |
| 14 | 黃樟腦 | Safrole | 1,3-benzodioxole, 5-(2-propenyl)- |
| 15 | 苯乙酸 | Ácido fenilacético | benzeneacetic acid |
| 16 | α-苯乙酰乙腈 | alfa-Fenilacetoacetonitrilo, APAAN | 3-oxo-2-phenylbutanenitrile |
| 17 | 4-苯胺-N-苯乙基哌啶 | 4-Anilino-N-phenethylpiperidine, ANPP | N-phenyl-1-(2-phenylethyl)piperidin-4-amine |
| 18 | N-苯乙基-4-哌啶酮 | N-Phenethyl-4-piperidone, NPP | 1-(2-phenylethyl)-piperidin-4-one |
| 19 | 3,4-亞甲基二氧苯基-2-丙酮甲基縮水甘油 | 3,4-MDP-2-P methyl glycidate | 2-oxiranecarboxylic acid, 3-(1,3-benzodioxol-5-yl)-2-methyl-, methyl ester |
| 20 | 3,4-亞甲基二氧苯基-2-丙酮甲基縮水甘油酸 | 3,4-MDP-2-P methyl glycidic acid | 2-oxiranecarboxylic acid, 3-(1,3-benzodioxol-5-yl)-2-methyl- |
| 21 | α-乙酰乙酸苯胺 | alpha-Phenylacetoacetamide, APAA | benzeneacetamide, α-acetyl- |
| 22 | α-苯乙酰乙酸甲酯 | Methyl alpha-Phenylacetoacetate, MAPA | methyl 3-oxo-2-phenylbutanoate |
| 23 | 4-AP | 4-AP | 4-piperidinamine, N-phenyl- |
| 24 | 1-boc-4-AP | 1-boc-4-AP | 4-(phenylamino)-1-piperidinecarboxylic acid, 1,1-dimethylethyl ester |
| 25 | 去甲芬太尼 | Norfentanyl | propanamide, N-phenyl-N-4-piperidinyl- |
| 列於本附表內物質的可能存在的鹽類。 | |||
| 本列於本附表內物質在其特定化學名稱下可能存在的異構體，但明確不列入本附表的異構體除外。 |
表六
| 編號 | 中文名稱 | 葡文名稱 | 化學名稱∕結構 |
|---|---|---|---|
| 1 | 丙酮 | Acetona | 2-propanone |
| 2 | 鄰氨基苯甲酸 | Ácido antranílico | 2-aminobenzoic acid |
| 3 | 乙醚 | Éter etílico | 1,1’-oxybis[ethane] |
| 4 | 鹽酸 | Ácido clorídrico | hydrochloric acid |
| 5 | 甲基乙基酮 | Metiletilcetona | 2-butanone |
| 6 | 哌啶 | Piperidina | piperidine |
| 7 | 硫酸 | Ácido sulfúrico | sulfuric acid |
| 8 | 甲苯 | Tolueno | methyl-benzene |
| 列於本附表內物質的可能存在的鹽類，但鹽酸鹽及硫酸鹽除外。 |